The anti-obesity effect of canaryseeds in addition to the inhibitory action of DPP-IV by canaryseed peptides would make this grain an excellent nutritional approach to improve the efficiency of synthetic drugs, since food derived DPP-IV inhibitors lack the potency of synthetic drugs inhibitors [35]. The gene discussed is DPP4; the disease is obesity due to melanocortin 4 receptor deficiency.